Morgan Stanley's exit below the 5% threshold removes a large passive holder from the register. Monitor for further institutional selling pressure and whether other large holders follow suit. The reduction occurred during Q3 2026, prior to the strong Q3 earnings report on October 28, suggesting the exit was not driven by near-term fundamentals.
Price Chart
How similar events traded
Executive Summary
Morgan Stanley filed an amended Schedule 13G disclosing a 2.8% passive stake in Axogen as of September 30, 2026, down from its prior 5%+ position, and stating it has ceased to be a beneficial owner of more than 5% of the class. The reduction from above 5% to 2.8% represents a significant exit by a major institutional holder.
Key Financial Metrics
Key Facts
- Morgan Stanley filed a Schedule 13G/A disclosing beneficial ownership of 1,662,486 shares of Axogen common stock as of September 30, 2026
- The stake represents 2.8% of shares outstanding
- Morgan Stanley stated it has ceased to be the beneficial owner of more than 5% of the class
- The filing is an amendment to a prior 13G filing, indicating a reduction from a previously disclosed >5% position
Financial Impact
Morgan Stanley reduced its stake from above 5% to 2.8%, a reduction of at least 1.3 million shares (based on ~$3.5B market cap and ~$97M stake value at 2.8%)
Risk Factors
- Loss of a major institutional holder may signal reduced confidence or portfolio rebalancing away from Axogen
- Potential for additional selling by other large holders if Morgan Stanley's exit is followed by other institutions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000895421-26-000342 |
| Document: 0000895421-26-000342-index.html | 0000895421-26-000342 |
| Document: 0000895421-26-000342.txt | 0000895421-26-000342 |
Track record
19 reports on AXGN
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +32.04% at T+20 after the Oct 1, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Viewing Entry $55.78 Now $55.38 +0.72% settles Dec 15
- Nov 9, 20267d ago 8-K Bullish 5/10 Entry $50.64 Now $55.38 +9.36% settles Dec 8
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $51.35 Now $55.38 +7.85% settles Dec 3
- Oct 28, 202619d ago 8-K Bullish 6/10 No price data
- Oct 28, 202619d ago Press Release Bullish 6/10 Entry $49.25 Now $55.38 +12.45% settles Nov 25
- Oct 2, 20266w ago SC 13G Neutral 4/10 Entry $37.22 to $49.37 Now $55.38 +48.79% ▲ +32.64% +35.11% vs SPY
- Oct 1, 20266w ago 8-K Bullish 6/10 Entry $37.39 to $49.37 Now $55.38 +48.11% ▲ +32.04% +33.85% vs SPY
- Oct 1, 20266w ago Press Release Bullish 6/10 Entry $37.39 to $49.37 Now $55.38 +48.11% ▲ +32.04% +33.85% vs SPY
- Sep 10, 20269w ago 424B5 Mixed 6/10 Entry $42.16 to $36.13 Now $55.38 +31.36% ▼ −14.30% −16.17% vs SPY
- Sep 10, 20269w ago 8-K Bullish 7/10 Entry $41.85 to $36.18 Now $55.38 +32.33% ▼ −13.55% −15.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers